<DOC>
	<DOCNO>NCT00030810</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high energy x-rays damage tumor cell . Combining chemotherapy radiation therapy surgery may shrink tumor remove surgery . PURPOSE : Phase II trial study effectiveness combination chemotherapy follow radiation therapy surgery treat patient stage IIIB non-small cell lung cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Followed Radiation Therapy Before Surgery Treating Patients With Stage IIIB NSCLC</brief_title>
	<detailed_description>OBJECTIVES : - Determine feasibility efficacy sequential neoadjuvant docetaxel , cisplatin , radiotherapy follow surgery patient operable stage IIIB non-small cell lung cancer . - Determine rate event-free survival 1 year patient treat regimen . - Determine operability complete resection rate patient treat regimen . - Determine postoperative 30-day mortality patient treat regimen . - Determine response rate , failure pattern , overall survival patient treat regimen . - Determine toxicity regimen patient . OUTLINE : This multicenter study . Patients receive docetaxel IV 1 hour cisplatin IV 1 hour day 1 . Treatment repeat every 3 week 3 course absence unacceptable toxicity . Beginning 3 week last chemotherapy dose , patient without progressive disease receive radiotherapy 1-2 time daily day 1-5 , 8-12 , 15-19 . Patients undergo surgery within 3-4 week completion radiotherapy . Patients follow 1 month every 3 month thereafter . PROJECTED ACCRUAL : A total 15-46 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm , operable stage IIIB nonsmall cell lung cancer T4 N03 M0 T14 N3 M0 bronchoscopy mediastinoscopy ( require assessment N3 disease ) CT scan MRI thorax Squamous cell Adenosquamous cell Large cell Poorly differentiate No prior concurrent metastatic disease CT scan MRI brain , bone scan , abdominal ultrasound CT scan No malignant pleural pericardial effusion No invasion aorta , esophagus , myocardium , supraclavicular node PATIENT CHARACTERISTICS : Age : 18 75 Performance status : WHO 01 Life expectancy : Not specify Hematopoietic : WBC least 4,000/mm^3 Platelet count least 100,000/mm^3 Hepatic : Bilirubin normal AST and/or ALT great 1.5 time upper limit normal ( ULN ) Alkaline phosphatase great 2.5 time ULN Renal : Creatinine clearance least 60 mL/min Cardiovascular : No unstable cardiac disease require treatment No congestive heart failure No angina pectoris ( even medically control ) No significant arrhythmia No myocardial infarction within past 3 month Other : Not pregnant nursing Fertile patient must use effective contraception No definite contraindication use corticosteroid premedication No preexisting grade 2 great peripheral neuropathy No active uncontrolled infection No uncontrolled diabetes mellitus No prior concurrent malignancy except nonmelanomatous skin cancer adequately treat carcinoma situ cervix No prior significant neurologic psychiatric disorder include psychotic disorder , dementia , seizure would preclude informed consent No serious underlie medical condition would preclude study participation No socioeconomic geographical circumstance would preclude study compliance PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : No concurrent corticosteroid except prophylactic pretreatment medication , treatment acute hypersensitivity reaction , chronic treatment ( initiated 6 month ago ) lowdose ( 20 mg methylprednisolone equivalent ) Radiotherapy : No prior radiotherapy chest Surgery : See Disease Characteristics Other : At least 30 day since prior treatment clinical trial No prior cytostatic therapy No concurrent experimental drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>squamous cell lung cancer</keyword>
	<keyword>large cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>adenosquamous cell lung cancer</keyword>
</DOC>